- Email: [email protected]
Tuberculous chorioretinitis
ARTICLES
Ventricular Enlargement (SAVE) study. J Am Coll Cardiol 1997; 29: 229–36. 11 Pfeffer MA, Braunwald E, Moye LA, et al, on behalf the SAVE investigators. Effect of captopril on mortality and morbididty in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327: 669–77. 12 The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821–28. 13 Kober L, Torp-Pedersen C, Carlsen JE, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 333: 1670–76.
14 Krumholz HM, Radford MS, Wang Y, et al. National use and effectiveness of beta blockers for the treatment of elderly patients after acute myocardial infarction. JAMA 1998; 280: 623–29. 15 Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta blockade on mortality among high risk and low risk patients after myocardial infarction. N Engl J Med 1998; 339: 489–97. 16 Dargie HJ, on behalf of the CAPRICORN Steering Committee. Design and methodology of the CAPRICORN trial: a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction. Eur J Heart Failure 2000; 2: 325–32. 17 Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet 2000; 355: 1575–81.
Clinical picture: tuberculous chorioretinitis Massimiliano Lanzafame, Marco Trevenzoli, Sandro Vento, Antonino Parrinello
Retinal fluorescein angiography of the left eye showing multiple dot-like lesions in a 21-year-old man with bilateral visual loss, a positive tuberculin skin test, and normal chest radiograph. He had been exposed 45 days earlier to a patient with cavitary pulmonary tuberculosis. Bilateral tubercular chorioretinitis gradually improved during the first 2 months of isoniazide, rifampicin, pyrazinamide, and streptomycin. Visual acuity was completely restored after 6 months of this antitubercular treatment. Unita Operativa di Malattie Infettive, Ospedale Civile Legnago,Verona,Italy, (M Lanzafame MD, M Trevenzoli MD, A Parrinello MD) Instituto di Immunologia e Malattie Infettive, Ospedale Civile Maggiore Borgo Trento, Verona (S Vento MD)
1390
THE LANCET • Vol 357 • May 5, 2001
For personal use. Only reproduce with permission from The Lancet Publishing Group.
Ventricular Enlargement (SAVE) study. J Am Coll Cardiol 1997; 29: 229–36. 11 Pfeffer MA, Braunwald E, Moye LA, et al, on behalf the SAVE investigators. Effect of captopril on mortality and morbididty in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327: 669–77. 12 The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821–28. 13 Kober L, Torp-Pedersen C, Carlsen JE, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 333: 1670–76.
14 Krumholz HM, Radford MS, Wang Y, et al. National use and effectiveness of beta blockers for the treatment of elderly patients after acute myocardial infarction. JAMA 1998; 280: 623–29. 15 Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta blockade on mortality among high risk and low risk patients after myocardial infarction. N Engl J Med 1998; 339: 489–97. 16 Dargie HJ, on behalf of the CAPRICORN Steering Committee. Design and methodology of the CAPRICORN trial: a randomised double blind placebo controlled study of the impact of carvedilol on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction. Eur J Heart Failure 2000; 2: 325–32. 17 Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet 2000; 355: 1575–81.
Clinical picture: tuberculous chorioretinitis Massimiliano Lanzafame, Marco Trevenzoli, Sandro Vento, Antonino Parrinello
Retinal fluorescein angiography of the left eye showing multiple dot-like lesions in a 21-year-old man with bilateral visual loss, a positive tuberculin skin test, and normal chest radiograph. He had been exposed 45 days earlier to a patient with cavitary pulmonary tuberculosis. Bilateral tubercular chorioretinitis gradually improved during the first 2 months of isoniazide, rifampicin, pyrazinamide, and streptomycin. Visual acuity was completely restored after 6 months of this antitubercular treatment. Unita Operativa di Malattie Infettive, Ospedale Civile Legnago,Verona,Italy, (M Lanzafame MD, M Trevenzoli MD, A Parrinello MD) Instituto di Immunologia e Malattie Infettive, Ospedale Civile Maggiore Borgo Trento, Verona (S Vento MD)
1390
THE LANCET • Vol 357 • May 5, 2001
For personal use. Only reproduce with permission from The Lancet Publishing Group.